Incidence of Recurrent NASH-Related Allograft Cirrhosis.
Publication/Presentation Date
5-1-2019
Abstract
BACKGROUND: Cirrhosis secondary to nonalcoholic steatohepatitis (NASH) is projected to become the leading indication for liver transplantation (LT) in the USA in the next decade. The long-term implications of post-LT NASH, specifically on the development of allograft cirrhosis, are not well known.
METHODS: A retrospective cohort of patients at a single large center undergoing LT for NASH from 2000 to 2015 was identified using a prospectively collected database. A total of 226 patients undergoing LT for NASH were identified. Mean follow-up for the cohort was 7 years. Seventy-five percent of patients underwent at least one liver biopsy post-LT.
RESULTS: Eighty-one patients (36%) developed recurrence of biopsy-proven NASH. Fifteen patients developed bridging fibrosis but only four patients (1.8%) progressed to recurrent NASH cirrhosis at a mean of 9 years post-LT. Body mass index at the time of LT was statistically higher in the NASH allograft cirrhosis group. Recurrent disease was less common and less severe in those transplanted with black donors. All four patients with recurrent NASH cirrhosis developed evidence of portal hypertension, but all remained alive at follow-up.
CONCLUSION: Although recurrent NASH following LT is common, the development of allograft cirrhosis is rare. These findings are useful when counseling patients and important to consider during their post-LT care.
Volume
64
Issue
5
First Page
1356
Last Page
1363
ISSN
1573-2568
Published In/Presented At
Kakar, S., Dugum, M., Cabello, R., Humar, A., Ahmad, J., & Malik, S. M. (2019). Incidence of Recurrent NASH-Related Allograft Cirrhosis. Digestive diseases and sciences, 64(5), 1356–1363. https://doi.org/10.1007/s10620-018-5413-9
Disciplines
Medicine and Health Sciences
PubMedID
30560336
Department(s)
Department of Medicine
Document Type
Article
